Streetbeat News

Stock Prices

SPY

The market on close imbalance is leaning towards the sell-side with $58M. This could potentially impact the SPY ETF.

Portfolio Pulse from Benzinga Newsdesk

July 28, 2023 | 7:34 pm

EBAY

ETSY

FTCH

SFIX

E-commerce stocks, including EBAY, ETSY, FTCH, and SFIX, are trading higher due to positive overall market sentiment.

Portfolio Pulse from Benzinga Newsdesk

July 28, 2023 | 7:32 pm

SNAP

Snap shares are trading higher, potentially rebounding after a recent fall due to quarterly earnings.

Portfolio Pulse from Benzinga Newsdesk

July 28, 2023 | 7:31 pm

IDXX

IDEXX Laboratories (NASDAQ:IDXX) has outperformed the market over the past 15 years, producing an average annual return of 22.42%. If an investor had bought $1000 of IDXX stock 15 years ago, it would be worth $20,488.34 today.

Portfolio Pulse from Benzinga Insights

July 28, 2023 | 7:30 pm

NXPI

NXP Semiconductors (NASDAQ:NXPI) has outperformed the market over the past 10 years by 10.08% on an annualized basis, producing an average annual return of 20.44%. If an investor had bought $100 of NXPI stock 10 years ago, it would be worth $685.05 today.

Portfolio Pulse from Benzinga Insights

July 28, 2023 | 7:30 pm

USB

U.S. Bancorp Inc. (NYSE:USB) shares are trading at $39.42, after a 1.55% increase. Over the past month, the stock went up by 19.31%, but fell by 17.01% in the past year. The company's P/E ratio of 10.81 is higher than the aggregate P/E ratio of the Banks industry (9.33), suggesting that the stock might be overvalued.

Portfolio Pulse from Benzinga Insights

July 28, 2023 | 7:30 pm

AMZN

DISH

DISH Network has announced a new partnership between Boost Infinite and Amazon, offering an exclusive deal for Prime members. This news has led to an increase in DISH Network's share prices.

Portfolio Pulse from Benzinga Newsdesk

July 28, 2023 | 7:28 pm

COUR

Coursera's shares are trading higher following better-than-expected revenue results. Cantor Fitzgerald and Keybanc have also raised their price targets on the stock.

Portfolio Pulse from Benzinga Newsdesk

July 28, 2023 | 7:27 pm

URGN

UroGen Pharma's shares are trading higher following the announcement of positive topline data from its Phase 3 trials ATLAS and ENVISION. The trials are studying UGN-102 for intravesical solution in patients with low-grade, intermediate-risk non-muscle invasive bladder cancer.

Portfolio Pulse from Benzinga Newsdesk

July 28, 2023 | 7:25 pm

MHK

Mohawk Industries' shares are trading lower after the company reported its Q2 earnings.

Portfolio Pulse from Benzinga Newsdesk

July 28, 2023 | 7:25 pm